viernes, 10 de enero de 2014

Today’s articles on Investing Ideas

Top Ideas

Despite Large Revenue Growth Splunk Is Overvalued
by ZNCapital

Editor's notes: A strategy to grow at any cost may end up costing shareholders. With profitability difficult to envision, shares of SPLK could fall substantially.

Danaos Corporation: Asymmetric Risk/Reward With Potential 200% Return
by Abdalla Al-ayrot

Editor's notes: With a relatively young fleet, and financial performance to improve following an end to derivative contracts, Danaos is set to deleverage and thrive. Shares could rise 200% over 2 years.

Northern Offshore: Improved Revenue Visibility Can Trigger More Than 55% Upside
by Street Smart Investor

Editor's notes: NOF.OL is likely to see double-digit revenue growth for the next two years yet it trades at a discounted valuation. Stock has 55% upside based on growth over the period.

Our Near-Term Bullish Call For Capstone Mining: $4 By Summer 2014
by Itinerant

Editor's notes: The coming release of an official and better-than-expected reserve estimate at a key mine will serve as a catalyst for CS.TO, leading to 50% upside.

Monster Worldwide: Either Way You Slice It, There's Still Upside Ahead
by Shaun Currie, CFA

Editor's notes: MWW's looming asset sale offers investors 40% upside, with an aggressive share buyback program providing a back-up plan to limit downside if the sale falls through.

Stocks Moving From Top Ideas

On Monday, BrooklynShorty called for trouble ahead at container leasing company TAL International, as the expiration of favorable leases would lead to dividend cuts, earnings misses, and a sharply lower share price. The stock is -14.3% to date. Read article »

On October 4, Whopper Investments predicted a turnaround at microcap medical equipment maker Pro-Dex which could lead to triple-digit upside. Shares are now +42.1% since his call. Read article »

Long Ideas

Sirius XM: A Closer Look At Fundamentals And Guidance by Crunching Numbers

Will Citigroup's Michael Corbat Come Through For Shareholders? by Bram de Haas

Intel: Understanding Intel by Russ Fischer

How Should You Play Micron Technology? by Christopher Salerno

BlackBerry: The Long-Term Picture by George Kesarios

Is Intel The Next Apple? by Charles Lewis Sizemore

Intel Might Disrupt Mobile With Intel Security Embedded Into Devices by Michael Blair

TMNG Global Is A Textbook Asymmetrical Special Situation by John Leonard

World Fuel Services: Another Bolt On Acquisition For This Growing Niche Player by The Value Investor

USA Technologies: An Undervalued Opportunity In An Underappreciated Market by The Behavioral Economist

Terra Nitrogen Poised To Rally Further by Chris Damas

Golden Queen Mining - The King Of Low-Cost Gold Miners? by The Investment Doctor

Stop Worrying About IBM's Revenues by Sean Weston

Merck Gets FDA Approval For New Formulation Of Isentress by Trefis

Mandalay Resources Is An Intriguing Speculative Gold And Silver Miner by Ben Kramer-Miller

ConocoPhillips: A Best Of Breed Energy Company by Seeking Profits

Liquid Natural Gas The Future Of Energy With Chevron Leading The Charge by Michael Grogan

Akamai: Q4 Could Be A Catalyst by William Meyers

More Catalysts On The Way For Spark by Mike Arnold

The Success Of Intercept Pharmaceuticals Is A Negative For Cumberland Pharmaceuticals by Paulo Santos

Petrobras's Refining Up 8% From A Year Ago, Stock Down 36% by Giovanni DiMauro

Green Mountain Coffee Roasters: The Fundamental King by Equities Lab

ModernGraham Valuation Of Bank Of New York Mellon by Benjamin Clark

Zacks' Bull Of The Day: Synaptics by Zacks Investment Research

Recent News At Durect Points To Bright Future by Jason Napodano

The McDonald's Upgrade Faces 2 Major Risks by Christopher F. Davis

Lululemon Athletica: A Good Investment For The Long Term. by Blackstone Equity Research

MSC Industrial Slowly Coiling The Spring by Stephen Simpson, CFA

Apollo Education Group: Turnaround In Play With Compelling Valuation by David Waldron

Berkshire Hathaway: Sum Of The Parts Suggests $100B Discount by RB Equity

Caterpillar: Dim Short Term Prospects But Bright Long Term Prospects by Balanced Investing

Rexahn's Replacement For Eli Lilly's Gemzar Enters New Clinical Trial by Sharon di Stefano

Kimberly Clark: Focusing On The Core Business by Cristina Tov

2014 Outlook: Can Marissa Mayer Continue Yahoo's Upward Trend? by El Torero

Vale: Undervalued But Risky by Lee Boy

Dumping McDonald's And Buying This Stock Can Boost Your Portfolio by Naman Shukla

Android Money Is Financing Microsoft's Lumia Phones And Tablets by Almario Alexej Alcaraz

Should You Sell On The Netflix Downgrade? by Quoth the Raven

Facebook Or Google? Maybe Choose Both by Michael Blair

Nobody Is Short Apple by Hedgemony

Capitalize On The Wealthy With This Stock by Alexander Valtsev

Bank Of America Will Continue Its Rise by IAEResearch

BlackBerry's Funeral May Have To Wait. It Seems To Have Returned From The Dead by Michael Blair

General Electric Well Positioned To Grow by IAEResearch

Ultratech Has To Deliver The Orders This Year by Stephen Simpson, CFA

Bioanalytical Systems: A Hidden Gem Among Profitable Biotech Companies by Sujan Lahiri

LeapFrog: My Best Small-Cap Idea For 2014 by Mario Squicciarini

What Will Be Driving Nokia In 2014? by Marsha Robe

ViryaNet: An Under The Radar Technology Gem's Cloud Transition Could Yield Significant Upside Potential by Tom Shaughnessy

Beam - An Attractive Investment Opportunity by Rahul Jaisingh

Astec Industries Is An Underplayed Investment On Infrastructure by Being Unordinary

Freeport-McMoRan Is A Solid Pick by IAEResearch

Our Top Idea: John B. Sanfilippo & Son - Significantly Undervalued And Underfollowed With Catalysts by Glyndon Park

ModernGraham Valuation Of Cigna Corporation by Benjamin Clark

Mulally Stays, Buy Ford by Detroit Bear

Lumpy Royalty Payments Are Masking CSP Inc.'s Improving Performance by Michael Bissell

2014 Prediction #5: Microsoft Tops $40 A Share by Bret Jensen

An Open Letter From Bulldog Investors, LLC To Kevin Landis Of Firsthand Technology Value Fund by Phillip Goldstein

A Real Opportunity Part 2: Real Goods Solar by The Opportunist

Nucor Vs. U.S. Steel, Why Nucor Might Be Better by Paul Boland

Organovo, The Missing Pieces by Stock Whisper

Aurora Oil & Gas Limited: Achieving The Same Amount Of Growth With Less Capital by Oil & Gas 360

SeaWorld: A Shamu-Sized Opportunity For Investors by Goudy Park Capital

Short Ideas

Microsoft: Promise Has Become A Problem by Bill Maurer

Apple Remains A Good Short by Michael Blair

Samsung And LG Could Eat Whirlpool's Lunch As The IoT Explodes In Home Appliances by Michael Blair

Veeva Systems Is A Valuation Outlier, Even Within The SaaS Bubble by AlphaBetter

YRC Worldwide And The December 'Financing Transactions' by Bookvalue Hunter

The Prisoner's Dilemma Demands Selling Twitter by Markos Kaminis

Growlife: What Are They Smoking? by Ryan Glover

Visa: Correction Is Needed In The Price by Blackstone Equity Research

Sears Holdings: A Turnaround Is Unlikely by Blackstone Equity Research

Why Chuy's Is Not The Next Chipotle by Asean Century

4 Reasons Why You Should Sell DryShips Right Now by Naman Shukla

History Could Repeat Itself At Hologic by SkyTides

Google May Be The Most Overrated Stock by Bill Maurer

ServiceNow: Widespread Mistakes In Analyst Share Counts Fuel Overvaluation by Kerrisdale Capital Management

Quick Picks & Lists

Buyout Picks In Healthcare For 2014 by EnhydrisPECorp

Vital Stem Cell Data And Development Coming In 2014 by Brian L. Wilson

Why GT Advanced Technologies' Sapphire Poses Little Threat To Corning's Gorilla Glass by Dan Strack

Investing In Oil Refinery Stocks: Trading The Spread by Oil and Gas Investments Bulletin

Riverbed Technology - In Play As Elliott Steps Up by The Value Investor

Are Generic Drug Stocks The Cure For A Hung-Over Health Care Market? by Cheryl Swanson

Undervalued Stock Of The Week: Navigant Consulting by Brad Kenagy

2014 Biotechnology Catalysts by Alexander Maxwell

iRobot Will Ride The Robotics Trend In 2014 by Andre Waldron

Forxiga Approval Should Be Boon For AstraZeneca And Bristol-Myers Squibb by J.J. McGrath

SandRidge - Sale, Deleveraging And Focus Increase Long-Term Appeal by The Value Investor

DryShips: Hit The Emergency Exit by Quoth the Raven

Google Glass Opens Profitable Opportunities For Himax Technologies, Infinity AR, And Glu Mobile by Johnny Duncan

Will Broadcom Turn Around In 2014? by Vinay Kumar Singh

2 Stocks That Can Boost Your Portfolio by Naman Shukla

On Trading: Appending My Trading Set - The Case For Dropping J.C. Penney by Nasser Khraishi

Why You Should Dump Whole Foods Market by Naman Shukla

American Short Line Railroads - 1 To Buy 2 To Watch And 3 To Forget About by Investor RockieK

Ford Is Ready To Move Higher by Bret Jensen

3 Stocks With Incredible Fundamentals by Marwood Capital

Top 10 Picks Return 41.2% In 2013: Predictions For The Future by Chris Katje

2013 Performance And 2014 Updates by DAG1996

Cisco CEO Highlights The 'Internet Of Things'; We Focus On RFID Plays Avery Dennison, Zebra Tech by AtonRa Partners

Healthcare Picks By Drug Type In 2014 by EnhydrisPECorp

Analysts Are Not Always Right: Buy These 2 Stocks Now by Morgan Myrmo

Why Investors Should Be Constantly Monitoring These Stocks by Profit Confidential

Capitalizing On Cannabis: Don't Get Caught In A 'Green Crush' by Alan Brochstein

Cramer's Picks

Cramer's Lightning Round - The Transition To Natural Gas Is Not Happening Fast Enough (1/9/14) by SA Editor Miriam Metzinger

Cramer's Mad Money - A Tale Of 2 Recent IPOs (1/9/14) by SA Editor Miriam Metzinger

Insider Ownership

Analog Devices: 6 Different Insiders Have Sold Shares During The Last 30 Days by Markus Aarnio

IPO Analysis

GlycoMimetics IPO Kicks Off 2014 IPO Action by Don Dion


Why are you receiving this? You subscribed to Investing Ideas at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.

To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.

Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001

No hay comentarios:

Publicar un comentario